News & Press

NEW YORK & PARIS, September 26, 2018 – TransPerfect Life Sciences, a leading provider of services and technologies to support global product development for the life sciences industry, today announced a strategic partnership with Arondor.
Charity Race in New York Unites Runners in Fight Against Cancer NEW YORK, NY, August 23, 2018 – TransPerfect, the world’s largest provider of language and technology solutions for global business, today announced that it has raised $120,000 for the V Foundation for Cancer Research through a combination of employee fundraising, corporate sponsorships, and other efforts related to its TransPerfect Victory Lap 5K Run/Walk.
NEW YORK, NY, May 29, 2018 – TransPerfect Life Sciences, a leading provider of services and technologies to support global product development for the life sciences industry, today announced the release of version 9.2 of Trial Interactive, their award-winning e-clinical platform.
NEW YORK, NY, February 13, 2018 - TransPerfect Life Sciences, a leading provider of services and technologies to support clinical trials and product development for the biopharmaceutical industry, today announced the release of myTI, the company’s ground-breaking mobile application that enables real-time eTMF access and functionality for study teams on the go.
NEW YORK, February 2, 2018 – TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that ARCA Biopharma has selected TransPerfect’s Trial Interactive eTMF solution as their enterprise platform for clinical trials.   
NEW YORK, NY, December 5, 2017 – TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced the hiring of Christine Morris and Jay Smith, two e-clinical and life sciences veterans, to its leadership team.
As an upgrade to the popular and well-received Trial Interactive 9.0 platform released earlier this year, version 9.1 is available immediately to multi-tenant clients and includes a modernized user interface, a variety of functionality improvements, and streamlined user workflows.
NEW YORK--(BUSINESS WIRE)--TransPerfect Life Sciences, a specialized division of TransPerfect, the world’s largest privately held provider of language and technology solutions for global business, today announced that it is presenting a session at the 2017 Drug Information Association (DIA) Annual Meeting, held June 19-21 in Chicago.
Newest Version of the Award-Winning Technology Enhances Security and Supports More Integrations
AGILITY CLINICAL CHOOSES TRANSPERFECT AS ETMF PROVIDER E-Clinical Solution Enables Migration to a Paperless Global Trial Process  
New Version of Award-Winning Platform Increases Transparency and Visibility
E-Clinical Solution Enables Karyopharm to Move to a Paperless Global Trial Process  
Integration Allows Schulman to Streamline eTMF Filing and Compliance for Life Sciences Clients  
NEW YORK, October 29, 2015 – TransPerfect, the world’s largest privately held provider of language and technology solutions for global business, today announced Q3 revenues of nearly $130 million, the highest total for this period in the company’s history and more than $10 million ahead of last year’s total for the same quarter.  
  Join us for a complementary webinar on Wednesday, June 10 at 1:00 PM EST!   Donna Dorozinsky of DWD & Associates will explore the latest TMF best practices and outline how e-clinical solutions can be employed to streamline clinical processes and prepare for inspection readiness.   Topics discussed: Utilization of the TMF Reference Model

Pages